Home › Crohn's Disease › Florida › Orlando

Pag-aaral pangklinika para sa Crohn's Disease sa Orlando, FL

Isang pag-aaral para sa Crohn's Disease ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Orlando. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Nagre-recruitPhase 3

AdventHealth Orlando ( Site 5131), Orlando
Endoscopic Research Inc ( Site 5061), Orlando

Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06430801

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Nagre-recruitPhase 2

Digestive And Liver Center Of Florida - Orlando /ID# 280924, Orlando
Clinical Research of Osceola /ID# 280593, Kissimmee · 16 mi ang layo

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Nagre-recruitPhase 4

Endoscopic Research, Inc., Orlando
Orlando Health-Orlando Regional Medical Center, Orlando
Digestive and Liver Center of Florida, P.A., Kissimmee · 16 mi ang layo

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06581328

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Nagre-recruitPhase 2

Endoscopic Research, Inc. /ID# 267211, Orlando
Novum Research /ID# 278128, Clermont · 24 mi ang layo

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06548542

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Nagre-recruitPhase 2

AdventHealth (Florida Hospital) Medical Group, Orlando

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06233461

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Nagre-recruitPhase 3

Orlando Health, Orlando
Digestive and Liver Center of Florida, Orlando

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Nagre-recruitPhase 3

AdventHealth Orlando-Site Number: 8400070, Orlando
Orlando Health, Inc.-Site Number: 8400084, Orlando
Clinical Research of Osceola-Site Number: 8400013, Kissimmee · 16 mi ang layo
at 1 pa

Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Nagre-recruitPhase 3

Orlando Health, Inc., Digestive Health Institute-Site Number: 8400084, Orlando
Clinical Research of Osceola-Site Number: 8400013, Kissimmee · 16 mi ang layo

Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07184944

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

Nagre-recruitPhase 3

Arnold Palmer Hospital for Children Center Digestive Health and Nutrition-Orland /ID# 255437, Orlando

Edad 2 hanggang 17 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT05995353

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Nagre-recruitPhase 2

Endoscopic Research Inc, Orlando
Clinical Research of Osceola, Kissimmee · 16 mi ang layo

Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06226883

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Nagre-recruitPhase 4

Endoscopic Research Inc, Orlando
Clinical Research of Osceola, Kissimmee · 16 mi ang layo

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06045754

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Nagre-recruit

Advent Health, Orlando

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT05230173

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

Nagre-recruitObservasyonal na pag-aaral

AdventHealth, Orlando

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT07237516

Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD

Nagre-recruitPhase 4

Digestive & Liver Center of Florida, Orlando

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 16, 2026 · NCT06997965

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Nagre-recruitPhase 2

Orlando Health, Inc., Orlando

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Abr 27, 2026 · NCT06456593

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

Nagre-recruitPhase 2

Investigational Site Number: 8400007, Orlando
Investigational Site Number: 8400017, Kissimmee · 16 mi ang layo

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 27, 2026 · NCT06958536

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Nagre-recruitPhase 2

Mirador Therapeutics Selected Site, Orlando

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Mar 12, 2026 · NCT07113522

Pag-aaral para sa Crohn's Disease sa ibang lungsod

Iba pang pag-aaral sa Orlando

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.